can you take glp 1 if you don't have diabetes Should Suddenly Stop Taking GLP-1s? Our Experts Weigh In GLP-1 for Prevention: Using Drugs

11 Impact on PharmD/CDCES: Pharmacists/CDCES can help identify patients that would most benefit from tirzepatides A1c lowering and weight reducing effects Pharmacists/CDCES can provide appropriate patient counseling regarding tirzepatides administration, benefits, adverse drug reactions, and storage Pharmacists/CDCES can assist other healthcare providers to safely transition patients from a GLP-1 RA to tirzepatide Pharmacists can facilitate insurance/cost barriers for eligible patients based on approved indications References: Type 2 diabetes treatment to lower A1C: Mounjaro(tirzepatide).Mounjaro

10.2174/1570162X11311030007 [DOI] [PubMed] [Google Scholar] 47.Agganis BT, Weiner DE, Giang LM, Scott T, Tighiouart H, Griffith JL, et al

aja F, et al

[Google Scholar] 6.Van Wijk R., Van Wijk E.P., Pang J., Yang M., Yan Y., Han J

An FDA approval decision is expected by the third quarter of 2025